Associations between chronic glycosylated haemoglobin (HbA1c) level and macular volume in diabetes patients without macular oedema

Acta Ophthalmologica

Volumn 88, Issue 7, 2010, Pages 753-758

  Yeung, Ling ^a,b   Sun, Chi Chin ^a,b   Ku, Wan Chen ^a,b   Chuang, Lan Hsin ^a,b   Chen, Chih Hung ^a,b   Huang, Bi Yu ^a,b   Ting, Ming Kuo ^a,b   Yang, Ko Jen ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

diabetic macular oedema; glycosylated haemoglobin; HbA1c; macular thickness; macular volume

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; CENTRAL SUBFIELD THICKNESS; CENTRAL SUBFIELD VOLUME; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA LUTEA; RETINA MACULA VOLUME; VISUAL SYSTEM PARAMETERS;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MACULA LUTEA; MACULAR EDEMA; MALE; MIDDLE AGED;

EID: 78349269558     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01711.x     Document Type: Article

References (28)

1. Antcliff RJ, &, Marshall J, (1999): The pathogenesis of oedema in diabetic maculopathy. Semin Ophthalmol 14: 223 - 232.
2. Antonelli-Orlidge A, Smith SR, &, D'Amore PA, (1989): Influence of pericytes on capillary endothelial cell growth. Am Rev Respir Dis 140: 1129 - 1131.
3. Browning DJ, McOwen MD, Bowen RM Jr, &, O'Marah TL, (2004): Comparison of the clinical diagnosis of diabetic macular oedema with diagnosis by optical coherence tomography. Ophthalmology 111: 712 - 715.
4. Browning DJ, Fraser CM, &, Clark S, (2008a): The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular oedema. Ophthalmology 115: 533 - 539.
5. Browning DJ, Glassman AR, Aiello LP, etal. & the Diabetic Retinopathy Clinical Research Network (2008b): Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular oedema. Ophthalmology 115: 1366 - 1371.
6. Ciulla TA, Harris A, Latkany P, Piper HC, Arend O, Garzozi H, &, Martin B, (2002): Ocular perfusion abnormalities in diabetes. Acta Ophthalmol Scand 80: 468 - 477.
7. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2000): Retinopathy and nephropathy in patients with type 1 diabetes 4years after a trial of intensive therapy. N Engl J Med 342: 381 - 389.
8. Early Treatment Diabetic Retinopathy Study Research Group (1985): Photocoagulation for diabetic macular oedema. ETDRS Study Report No. 1. Arch Ophthalmol 103: 1796 - 1806.
9. Early Treatment Diabetic Retinopathy Study Research Group (1991): Grading diabetic retinopathy from stereoscopic colour fundus photographs - an extension of the modified Airlie House classification. ETDRS Report No. 10. Ophthalmology 98: 786 - 806.
10. Ferris FL III, &, Patz A, (1984): Macular oedema. A complication of diabetic retinopathy. Surv Ophthalmol 28: 452 - 461.
11. Fraser-Bell S, Kaines A, &, Hykin PG, (2008): Update on treatments for diabetic macular oedema. Curr Opin Ophthalmol 19: 185 - 189.
12. Hee MR, Puliafito CA, Duker JS, etal. (1998): Topography of diabetic macular oedema with optical coherence tomography. Ophthalmology 105: 360 - 370.
13. Higgins GT, Khan J, &, Pearce IA, (2007): Glycaemic control and control of risk factors in diabetes patients in an ophthalmology clinic: what lessons have we learned from the UKPDS and DCCT studies? Acta Ophthalmol Scand 85: 772 - 776.
14. Holm K, Larsson J, &, Lovestam-Adrian M, (2007): In diabetic retinopathy, foveal thickness of 300μm seems to correlate with functionally significant loss of vision. Doc Ophthalmol 114: 117 - 124.
15. Kayykcyolu O, Ozmen B, Seymenoglu G, Tunali D, Kafesciler SO, Guclu F, &, Hekimsoy Z, (2007): Macular oedema in unregulated type 2 diabetic patients following glycaemic control. Arch Med Res 38: 398 - 402.
16. Klein R, Klein BE, Moss SE, &, Cruickshanks KJ, (1995): The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The longterm incidence of macular oedema. Ophthalmology 102: 7 - 16.
17. Knudsen LL, (2007): Identification of diabetic macular oedema using retinal thickness measurements. Acta Ophthalmol Scand 85: 27 - 31.
18. Neubauer AS, Chryssafis C, Priglinger SG, Haritoglou C, Thiel M, Welge-Lüssen U, Kampik A, &, Ulbig MW, (2007): Topography of diabetic macular oedema compared with fluorescein angiography. Acta Ophthalmol Scand 85: 32 - 39.
19. Sakata K, Funatsu H, Harino S, Noma H, &, Hori S, (2006): Relationship between macular microcirculation and progression of diabetic macular oedema. Ophthalmology 113: 1385 - 1391.
20. Sakata K, Funatsu H, Harino S, Noma H, &, Hori S, (2007): Relationship of macular microcirculation and retinal thickness with visual acuity in diabetic macular oedema. Ophthalmology 114: 2061 - 2069.
21. Schaudig UH, Glaefke C, Scholz F, &, Richard G, (2000): Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular oedema. Ophthalmic Surg Lasers 31: 182 - 186.
22. Shimura M, Nakazawa T, Yasuda K, Shiono T, Iida T, Sakamoto T, &, Nishida K, (2008): Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular oedema. Am J Ophthalmol 145: 854 - 861.
23. Sims DE, (1986): The pericyte - a review. Tissue Cell 18: 153 - 174.
24. Soliman W, Sander B, &, Jørgensen TM, (2007): Enhanced optical coherence patterns of diabetic macular oedema and their correlation with the pathophysiology. Acta Ophthalmol Scand 85: 613 - 617.
25. Soliman W, Sander B, Hasler PW, &, Larsen M, (2008): Correlation between intraretinal changes in diabetic macular oedema seen in fluorescein angiography and optical coherence tomography. Acta Ophthalmol 86: 34 - 39.
26. UK Prospective Diabetes Study (UKPDS) Group (1998): Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837 - 853.
27. Virgili G, Menchini F, Dimastrogiovanni AF, Rapizzi E, Menchini U, Bandello F, &, Chiodini RG, (2007): Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular oedema: a systematic review. Invest Ophthalmol Vis Sci 48: 4963 - 4973.
28. Wiemer NG, Eekhoff EM, Simsek S, Heine RJ, Ringens PJ, Polak BC, &, Dubbelman M, (2008): The effect of acute hyperglycaemia on retinal thickness and ocular refraction in healthy subjects. Graefes Arch Clin Exp Ophthalmol 246: 703 - 708.